Showing results (121-130 of 149) with videos related to
Sort By:
Pageof 15
Cancer Research Communications|August 7, 2023
The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate CancerLucie Van Emmenis, Sheng-Yu Ku, Kaitlyn Gayvert, et al.Nature Genetics|October 15, 2013
Frequent truncating mutations of STAG2 in bladder cancerDavid A Solomon, Jung-Sik Kim, Jolanta Bondaruk, et al.Nature Communications|July 7, 2019
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signalingBrian D Robinson, Panagiotis J Vlachostergios, Bhavneet Bhinder, et al.The Journal of Urology|June 16, 2012
Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinomaMichael Rink, Brian D Robinson, David A Green, et al.Nature Communications|November 20, 2024
Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancerShankha S Chatterjee, Juan F Linares, Tania Cid-Diaz, et al.Placenta|February 28, 2017
Androgen dependent mechanisms of pro-angiogenic networks in placental and tumor developmentVeronika M Metzler, Simone de Brot, Robert S Robinson, et al.Frontiers in Genetics|February 3, 2023
Clinical and molecular significance of the RNA m6A methyltransferase complex in prostate cancerJennifer Lothion-Roy, Daisy B Haigh, Anna E Harris, et al.Proceedings of the National Academy of Sciences of the United States of America|June 26, 2012
Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesisChiara Grisanzio, Lillian Werner, David Takeda, et al.Cancers|October 27, 2022
The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate CancerDaisy B Haigh, Corinne L Woodcock, Jennifer Lothion-Roy, et al.Nature|November 26, 2025
NSD2 targeting reverses plasticity and drug resistance in prostate cancerJia J Li, Alessandro Vasciaveo, Dimitris Karagiannis, et al.Pageof 15